Antiplatelet or anticoagulant therapy might not increase the risk of haemoptysis in patients with bronchiectasis

被引：0

作者：

Lee, J. ^{[1
]}

Park, Y. S. ^{[1
]}

Lee, C-H. ^{[1
]}

Lee, S-M. ^{[1
]}

Yoo, C-G. ^{[1
]}

Kim, Y. W. ^{[1
]}

Han, S. K. ^{[1
]}

Yim, J-J ^{[1
]}

机构：

[1] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul 110744, South Korea

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2013年 / 17卷 / 07期

关键词：

bronchial artery embolisation; aspirin; warfarin; ASPIRIN;

D O I：

10.5588/ijtld.12.0807

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The aim of this study was to assess whether the use of antiplatelets and anticoagulants increased haemoptysis in patients with bronchiectasis. Cases (n = 242) with a history of haemoptysis were compared with controls (n = 242) without a history of haemoptysis. Of the 242 case patients, 16.5% took antiplatelets compared with 19.8% of controls (P = 0.346). The proportion of warfarin users did not differ between cases and controls (3.3% vs. 2.5%, P = 0.588). The use of these agents might not be associated with increased risk of haemoptysis in patients with bronchiectasis.

引用

页码：989 / 991

页数：3

共 50 条

[41] Antiplatelet and anticoagulant therapy in patients with submacular hemorrhage caused by neovascular age-related macular degeneration
Weber, Constance
Bertelsmann, Maria
Kiy, Zoe
Stasik, Isabel
Holz, Frank G.
Liegl, Raffael
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (05) : 1413 - 1421
[42] Recanalization after Extracranial Dissection: Effect of Antiplatelet Compared with Anticoagulant Therapy
Ramchand, Preethi
Mullen, Michael T.
Bress, Aaron
Hurst, Robert
Kasner, Scott E.
Cucchiara, Brett L.
Messe, Steven R.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (02) : 438 - 444
[43] A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs
Taylor, Kellie
Filgate, Rhys
Guo, Ding Yu
Macneil, Finlay
BJU INTERNATIONAL, 2011, 108 : 45 - 50
[44] Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications
Bordeaux, Jeremy S.
Martires, Kathryn J.
Goldberg, Dori
Pattee, Sean F.
Fu, Pingfu
Maloney, Mary E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 65 (03) : 576 - 583
[45] Assessing Bleeding Risk in Patients With Intentional Overdoses of Novel Antiplatelet and Anticoagulant Medications
Levine, Michael
Beuhler, Michael C.
Pizon, Anthony
Cantrel, F. Lee
Spyres, Meghan B.
LoVecchio, Frank
Skolnik, Aaron B.
Brooks, Daniel E.
ANNALS OF EMERGENCY MEDICINE, 2018, 71 (03) : 273 - 278
[46] The Impact of Antiplatelet and Anticoagulant Therapies on Gastrointestinal Symptoms in Patients with Atrial Fibrillation: A Systematic Review
Sobieraj, Diana M.
White, C. Michael
Alikhanov, Sabina
Winkler, Sara
Mediouni, Malek
Kluger, Jeffrey
Coleman, Craig I.
ANNALS OF PHARMACOTHERAPY, 2012, 46 (09) : 1220 - 1231
[47] Short-term prognosis of intracranial haemorrhage in patients on oral anticoagulant or antiplatelet drugs
Pomero, Fulvio
Melchio, Remo
Sironi, Anna
Giraudo, Alessia Valentina
Dentali, Francesco
Fenoglio, Luigi Maria
Squizzato, Alessandro
THROMBOSIS RESEARCH, 2013, 132 (06) : 765 - 769
[48] Antiplatelet Therapy as a Risk Factor for Microbleeds in Intracerebral Hemorrhage Patients: Analysis Using Specific Antiplatelet Agents
Naka, Hiromitsu
Nomura, Eiichi
Kitamura, Jyuri
Imamura, Eiji
Wakabayashi, Shinichi
Matsumoto, Masayasu
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (06) : 834 - 840
[49] PREVENTION OF THROMBOEMBOLISM IN ATRIAL-FIBRILLATION - ANTIPLATELET AND ANTICOAGULANT-THERAPY
KIENAST, J
ZEITSCHRIFT FUR KARDIOLOGIE, 1994, 83 : 49 - 58
[50] Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis
Chen, Xi
Xu, Jiawen
Chen, Shidong
Dong, Qiang
Dong, Yi
STROKE AND VASCULAR NEUROLOGY, 2022, 7 (04) : 271 - 275

← 1 2 3 4 5 →